Hydrocortisone Valerate
Who holds supplier records for Hydrocortisone Valerate? 5 organisations hold a current record for Hydrocortisone Valerate: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: France (1), India (1), Malaysia (1), Israel (1) and 1 other country (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Hydrocortisone Valerate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/hydrocortisone-valerate
Reading the evidence
- 5 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (5)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Hydrocortisone Valerate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- EUROAPI FRANCEFrance Company GMP cert on recordActive DMF 4662 · latest filing Sept 1982
- Lupin LimitedIndia Company GMP cert on recordActive DMF 31143 · latest filing Dec 2016
- SYMBIOTICA SPECIALITY INGREDIENTS SDN BHDMalaysiaActive DMF 31423 · latest filing Feb 2017
- Taro Pharmaceutical Industries Ltd.Israel Company GMP cert on recordActive DMF 13921 · latest filing Dec 1998
- TRIFARMA SPAItaly Company GMP cert on recordActive DMF 33334 · latest filing Dec 2018
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (3)
Organisations whose Type II DMFs for Hydrocortisone Valerate are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- YANGZHOU PHARMACEUTICAL CO LTDInactive DMF 30971 · filed Sept 2016
- SOCIETA ITALIANA CORTICOSTEROIDI SPAInactive DMF 3979 · filed Nov 1980
- Brazil · Inactive DMF 2185 · filed Oct 1972
Overview
Hydrocortisone Valerate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200562).
Chemical identity
- IUPAC name
- [(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] pentanoate
- Canonical SMILES
- CCCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)C(=O)CO
- InChIKey
- FZCHYNWYXKICIO-FZNHGJLXSA-N
- Synonyms
- Cortisol 17-valerate, Hydrocortisone 17-valerate, Hydrocortisone valerate, NSC-759133, Westcort, CHEBI:50865, RefChem:55354, hydrocortisone valerate cream, Hydrocortisone-17-valerate, C26H38O6, Hydrocortisone valerate [USAN], Westcort (TN)
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Corticosteroid
- Mechanism of action
- Corticosteroid Hormone Receptor Agonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Hydrocortisone Valerate?
5 organisations hold an active US FDA Type II Drug Master File or a CEP for Hydrocortisone Valerate: EUROAPI FRANCE (France), Lupin Limited (India), SYMBIOTICA SPECIALITY INGREDIENTS SDN BHD (Malaysia), Taro Pharmaceutical Industries Ltd. (Israel) and TRIFARMA SPA (Italy). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Hydrocortisone Valerate Drug Master Files are active?
EUROAPI FRANCE (DMF 4662), Lupin Limited (DMF 31143), SYMBIOTICA SPECIALITY INGREDIENTS SDN BHD (DMF 31423), Taro Pharmaceutical Industries Ltd. (DMF 13921) and TRIFARMA SPA (DMF 33334). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Hydrocortisone Valerate records mean?
3 organisations have only inactive Type II DMFs for Hydrocortisone Valerate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Hydrocortisone Valerate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Hydrocortisone Valerate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.